Daniel J.F.M. Thuijs, MD, Erasmus University, Rotterdam, the Netherlands, presented these 10-year findings from close to 2000 patients in the SYNTAX Extended Survival (SYNTAXES) trial here at the ...

PARIS — Ten-year follow-up data from the SYNTAXES trial highlight no significant difference in all-cause death among patients who underwent PCI using first-generation paclitaxel-eluting stents ...

Cite this: SYNTAXES: Female Benefit With CABG Vanishes by 10 Years - Medscape - Aug 19, 2020. Comments. Commenting is limited to medical professionals. To comment please Log-in. Comments ...

SAN DIEGO — In preliminary 10-year results of the SYNTAXES study presented at TCT 2018, there was no significant difference in survival between patients who had CABG and those who had PCI with a ...

PARIS, France—The full and final 10-year results from the SYNTAX Extended Survival Trial (SYNTAXES) suggest that CABG confers a mortality advantage over PCI for patients with three-vessel disease, but ...

For the SYNTAXES study, which will also be presented at the upcoming virtual European Society of Cardiology Congress, Serruys, Hironori Hara, MD (University of Amsterdam, the Netherlands), and ...

The same applies to syntaxes or other documentation that does not contain data. 2. Preparing exports If you wish to remove data from the secure environment, you must always use the export folder. The ...